UCL  IRIS
Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Publication Detail
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies
  • Publication Type:
    Journal article
  • Publication Sub Type:
    Article
  • Authors:
    Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, Lundberg I, Morrison C, Oakley L, Oakley I, Pilkington C, Vencovsky J, Vincent K, Scott DL, Isenberg DA
  • Publication date:
    11/2001
  • Pagination:
    1262, 1273
  • Journal:
    RHEUMATOLOGY (OXFORD)
  • Volume:
    40
  • Issue:
    11
  • Keywords:
    adult, assessment, Core, disease, idiopathic, MYOPATHY, outcome, OUTCOMES, RU, Outcome assessment, activity, adult, Anatomy, As, ASSESSMENTS, Child, clinical, Clinical trial, Clinical Trials, CLINICAL-TRIAL, CLINICAL-TRIALS, CONFERENCE, Consensus, Damage, development, diagnosis, DISEASE-ACTIVITY, domain, DOMAINS, DURATION, enzyme, Enzymes, Form, function, global, health, Health related quality of life, Health Survey, Health-related quality of life, IM, INSTRUMENT, INSTRUMENTS, international consensus, LA, LIFE, measurement, medical, Multidisciplinary, muscle, Muscle Disease, Myositis, OF-LIFE, ORDER, outcome assessment (health care), Outcome measures, paediatric, pathology, Patient, patients, PERSISTENT, physical, physician, physiopathology, PUBLISHED, QUALITY, Quality of Life, QUALITY-OF-LIFE, Review, SERA, serum, Specialist, strength, Support, Non-U.S.Gov't, Survey, therapeutic, TOOL, TRIAL, TRIALS, Use, VALIDATION
  • Notes:
    UI - 21567622 LA - eng PT - Consensus Development Conference PT - Journal Article PT - Review DA - 20011116 IS - 1462-0324 SB - IM CY - England
Abstract
In order to develop a preliminary core set of disease outcome measures for use in clinical trials of idiopathic inflammatory myopathies (IIM), we evaluated those measures used in previous trials, assessed the validation of published instruments and discussed these at an international consensus conference. The initial proposals were further refined by a multidisciplinary group of adult and paediatric specialists experienced in IIM using the Delphi method. The proposed preliminary core set of disease activity measures consists of five domains: physician and patient/parent global assessments of disease activity; muscle strength; physical function; serum activity of muscle enzymes; and an assessment tool to capture extra-skeletal muscle disease activity. The group recommended further development of a core set of disease damage measures for assessment of persistent changes in anatomy, pathology and function of at least 6 months' duration. The group recommended that patient-reported outcomes should include generic health-related quality of life assessments using the Medical Outcomes Study 36-item Short Form (SF-36) health survey in adult IIM patients and a validated quality of life instrument for paediatric patients. We propose the core set of outcome measures as a minimum group of assessments to include in all IIM therapeutic studies. The use of this core set should assist in standardizing outcome measurement and in optimizing therapeutic trials in myositis
Publication data is maintained in RPS. Visit https://rps.ucl.ac.uk
 More search options
UCL Researchers
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by